CDK2 and acute myeloid leukemia: Since MDS/AML are characterized by ineffective hematopoiesis due to block in myeloid differentiation, we performed a search for the TRAF6 motif in cell cycle regulators and determined that CDK2 could be a potential substrate (Figure 3A).